• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Pharmacokinetics and residues of oxytetracycline and oxolinic acid in black tiger shrimp (Penaeus monodon) and the effect of cooking on the residues

Research Project

Project/Area Number 14580166
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field 食生活
Research InstitutionAichi Konan College

Principal Investigator

UNO Kazuaki  Aichi Konan College, Department of Sciences for Living, Associate professor, 生活科学科, 助教授 (80223585)

Co-Investigator(Kenkyū-buntansha) AOKI Takahiko  Mie University, Faculty of Bioresources, Associate professor, 生物資源学部, 助教授 (00212366)
Project Period (FY) 2002 – 2004
Project Status Completed (Fiscal Year 2004)
Budget Amount *help
¥3,100,000 (Direct Cost: ¥3,100,000)
Fiscal Year 2004: ¥500,000 (Direct Cost: ¥500,000)
Fiscal Year 2003: ¥800,000 (Direct Cost: ¥800,000)
Fiscal Year 2002: ¥1,800,000 (Direct Cost: ¥1,800,000)
KeywordsBlack tiger shrimp / Oxytetracycline / Oxolinic acid / Pharmacokinetics / Residues / Cooking / Penaeus monodon / 国際研究者交流 / タイ国 / バイオアベイラビリティ / ウシエビ / 残留性
Research Abstract

The pharmacokinetics and residues of oxytetracycline (OTC) and oxolinic acid (OA) were examined in black tiger shrimp (Penaeus monodon, 18-25 g shrimp) after intra-sinus (10 mg/kg) and oral (50 mg/kg) administration. The shrimp were kept in tanks with seawater at a salinity of 5-10 ppt. The water temperature was adjusted to 28-29℃. The hemolymph concentrations of both drugs after intra-sinus dosing were best described by a two-compartment open model. The following equations were obtained to describe the time course of hemolymph levels for two drugs :
Oxytetracycline : Ct=35.4・exp(-3.5303・t)+10.6・exp(-0.0429・t)
Oxolinic acid : Ct=9.96・exp(-0.8252・t)+3.88・exp(-0.0391・t)
The distribution and elimination half-lives were found to be 0.2 and 16.2 h for OTC and 0.84 and 17.7 h for OA. The apparent volume of distribution at a steady state and total body clearance were estimated to be 869 ml/kg and 38.7 ml/kg/h for OTC and 2,061 ml/kg and 90.1 ml/kg/h for OA, respectively.
The peak hemolymph concentration and the time to peak hemolymph concentration following oral dose were 21.1 μg/ml at 4 h for OTC and 4.20 μg/ml at 4 h for OA. The bioavailability after oral administration was 35.6% for OTC and 7.9% for OA. The elimination half-life of muscle was 22.0 h for OTC and 20.2 h for OA. The elimination half-life of shell was 21.9 h for OA, however, for OTC the elimination half-life of shell could not calculated because the drug residues persisted in shell tissues.
Residual OTC in muscle was reduced to 50〜60% by the boiling for 4 min and frying at 180℃ for 1 min, and 30〜40% baking at 200℃ for 4 min. However, the reduction levels in shell were only 20%. Residual OA was 20〜30% in muscle and shell by the cooking.

Report

(4 results)
  • 2004 Annual Research Report   Final Research Report Summary
  • 2003 Annual Research Report
  • 2002 Annual Research Report
  • Research Products

    (3 results)

All 2004 Other

All Journal Article (2 results) Publications (1 results)

  • [Journal Article] Pharmacokinetics of oxolinic acid and oxytetracycline in kuruma shrimp, Penaeus japonicus2004

    • Author(s)
      Kazuaki Uno
    • Journal Title

      Aquaculture 230

      Pages: 1-11

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Pharmacokinetics of oxolinic acid and oxytetracycline in kuruma shrimp, Penaeus japonicus.2004

    • Author(s)
      Kazuaki Uno
    • Journal Title

      Aquaculture 230

      Pages: 1-11

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Publications] Kazuaki Uno: "Pharmacokinetics of oxolinic acid and oxytetracycline in kuruma shrimp, Penaeus japonicus"Aquaculture. 230・1-4. 1-11 (2004)

    • Related Report
      2003 Annual Research Report

URL: 

Published: 2002-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi